Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Study Assessing the Predictive Value of TMPRSS2-ERG Gene Fusion and PTEN Deletion in High Risk Prostate Cancer Patients

NCT01350180 is registered in ClinicalTrials.gov with Dr. Tamim Niazi as lead sponsor.

NCT NCT01350180
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01350180 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Study Assessing the Predictive Value of TMPRSS2-ERG Gene Fusion and PTEN Deletion in High Risk Prostate Cancer Patients
Lead sponsor
Dr. Tamim Niazi
Phase
Observational
Overall status
Withdrawn
Start date
September 30, 2010
Completion date
December 1, 2022
Enrollment
0 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer